These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2875547)

  • 41. The outcome of reflux oesophagitis: does drug-induced remission mean cure?
    Savarino V; Celle G
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):475-7. PubMed ID: 9836098
    [No Abstract]   [Full Text] [Related]  

  • 42. Over the counter sales of histamine-2 receptor antagonists.
    Petersen H
    Scand J Gastroenterol Suppl; 1988; 155():20-2. PubMed ID: 2907682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cimetidine and ranitidine in the treatment of reflux esophagitis].
    Kimmig JM
    Z Gastroenterol; 1984 Aug; 22(8):373-8. PubMed ID: 6091353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Scarpignato C
    Dig Liver Dis; 2005 Jul; 37(7):468-74. PubMed ID: 15893968
    [No Abstract]   [Full Text] [Related]  

  • 46. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 47. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R
    J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
    [No Abstract]   [Full Text] [Related]  

  • 48. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PPIs vs H2RAs for erosive reflux esophagitis.
    King VJ
    J Fam Pract; 1998 Mar; 46(3):199-200. PubMed ID: 9519012
    [No Abstract]   [Full Text] [Related]  

  • 50. Reflux esophagitis in infants and children: a report from the Working Group on Gastro-Oesophageal Reflux Disease of the European Society of Paediatric Gastroenterology and Nutrition.
    Vandenplas Y
    J Pediatr Gastroenterol Nutr; 1994 May; 18(4):413-22. PubMed ID: 7915307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing recurrent oesophagitis.
    Scand J Gastroenterol Suppl; 1989; 168():16-22; discussion 27-9. PubMed ID: 2575791
    [No Abstract]   [Full Text] [Related]  

  • 52. [Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese patients].
    Ohara S; Haruma K; Kinoshita Y; Kusano M
    Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):588-97. PubMed ID: 20379093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Dyspepsia--a challenge in daily practice].
    Krag E
    Ugeskr Laeger; 1991 Aug; 153(32):2211. PubMed ID: 1679262
    [No Abstract]   [Full Text] [Related]  

  • 54. Comments on therapeutic interchange of histamine H2-receptor antagonists.
    Am J Hosp Pharm; 1990 Mar; 47(3):523-4. PubMed ID: 1969229
    [No Abstract]   [Full Text] [Related]  

  • 55. Personal experience in TCM treatment of reflux esophagitis.
    Hong L
    J Tradit Chin Med; 2003 Sep; 23(3):175-6. PubMed ID: 14535176
    [No Abstract]   [Full Text] [Related]  

  • 56. Reactions to cimetidine.
    Grimson TA
    Lancet; 1977 Apr; 1(8016):858. PubMed ID: 67365
    [No Abstract]   [Full Text] [Related]  

  • 57. [Histamine-2 blockade in skin disease].
    Nielsen HJ; Nielsen H
    Ugeskr Laeger; 1989 May; 151(22):1407. PubMed ID: 2567542
    [No Abstract]   [Full Text] [Related]  

  • 58. H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.
    Leary PJ; Hess E; BarĂ³n AE; Branch KR; Choudhary G; Hough CL; Maron BA; Ralph DD; Ryan JJ; Tedford RJ; Weiss NS; Zamanian RT; Lahm T
    Am J Respir Crit Care Med; 2018 Jun; 197(12):1638-1641. PubMed ID: 29437490
    [No Abstract]   [Full Text] [Related]  

  • 59. H2 receptor antagonists for protal hypertension.
    Daneshmend TK; Roberts CJ
    Lancet; 1981 Aug; 2(8242):360. PubMed ID: 6115127
    [No Abstract]   [Full Text] [Related]  

  • 60. H2 antagonists and the common cold.
    Sicore A
    Ann Intern Med; 1986 Nov; 105(5):803. PubMed ID: 2876671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.